Inhibitory effects of cisplatin and its conjugate with glutathione on blood platelet activity

Platelets

Volumn 9, Issue 1, 1998, Pages 69-72

  Olas, B ^a   Wachowicz, B ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE; ARACHIDONIC ACID; CISPLATIN; GLUTATHIONE; MALONALDEHYDE; PROTEIN; THROMBIN; THROMBOXANE A2;

ARACHIDONIC ACID METABOLISM; ARTICLE; CELL GRANULE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG CYTOTOXICITY; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; THROMBOCYTE AGGREGATION;

EID: 0031905476     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537109877031     Document Type: Article

References (23)

1. Keppler BK. Metal complexes in cancer chemotherapy. In: Keppler BK, ed. Metal Complexes in Cancer Chemotherapy. New York: Weinheim, 1993: 1-8
2. Muggia FM, Los G. Platinum resistance: laboratory findings and clinical implications. Stem Cells 1993; II: 182-93.
3. Weiss RB, Christian MC. New cisplatin analogues in development. Drugs 1993; 46: 360-77.
4. Kruidering M, van de Water B, de Heer E, Mulder GJ, Nagelkerke JF. Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to II of the respiratory chain. J Pharmacol Exp Ther 1997; 280: 638-49.
5. Goad KE, Gralnick HR. Coagulation disorders in cancer. Compl Cancer 1996; 10: 457-84.
6. Ulich TR, del Castillo J, Yin S, Swift S, Padilla D, Senaldi G, Bennett L, Shutter J, Bogenberger J, Sun D, Samal B, Shimamoto G, Lee R, Steinbrik R, Boone T, Sheridow, Hunt P. Megakaryiocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice. Blood 1995; 86: 971-6.
7. Treskes M, van der Vijgh WJF. WR2721 as a modulation of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach. Cancer Chemother 1993; 33: 93-106.
8. Odenhaimer B, Wolf W. Reactions of cisplatin with sulfur containing amino acids and peptides. I. Cysteine and glutathione. Inorg Chim Acta 1991; 38: 95-9.
9. Olas B, Wachowicz B. Cisplatin-induced changes of biological activity of blood platelets: thiol-related mechanisms. Anti-Cancer Drugs 1996; 7: 476-82.
10. Wachowicz B. Inhibitory effect of cisplatin on the enzymatic peroxidation of platelet endogenous arachidonate. Cytobios 1993; 75: 157-62.
11. Wachowicz B, Olas B. Changes of platelet cytoskeleton induced by cisplatin in relation to platelet activation. Biomed Lett 1995; 52: 181-90.
12. Shirazi FH, Molepo JM, Steward DJ, Ng CE, Raaphorst GP, Goel R. Cytotoxicity, accumulation and efflux of cisplatin and its metabolities in human ovarian carcinoma cells. Toxicol Appl Pharmacol 1996; 140: 211-8.
13. Daley-Yotes PT, McBrien DCH. Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumor activity of cisplatin. Biochem Pharmacol 1984; 33: 3063-70.
14. Ishikawa T, Ali-Osman F. Glutathione-associated cis-diamminedichloroplatinum (II) metabolism and ATP dependent efflux from leukemia cells. J Biol Chem 1993; 268: 20116-25.
15. Vatassary GT, Smith WE. Determination of α-tocopherolquinone (vitamin B quinone) in human serum, platelets, and red cell membrane samples. Analyt Biochem 1987; 167: 411-7.
16. Wachowicz B. Adenine nucleotides in thrombocytes of birds. Cell Biochem Funct 1984; 2: 167-70.
17. Smith JB, Ingerman CM, Silver MJ. Malondialdehyde formation as an indicator of prostaglandin production by human platelets. J Lab Clin Med 1976; 88: 167-72.
18. Corden BJ. Reaction of platinum (II) antitumor agent with sulfhydryl compounds and the implications for nephrotoxicity. Inorg Chim Acta 1987; 137: 125-30.
19. Wachowicz B, Krajewski T, Olas B, Zbikowska HM. Effects of cisplatin and selenite on the level of thiols in pig blood platelets. J Physiol Pharmacol 1995; 46: 97-103.
20. Chen G, Waxman DJ. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells. Biochem Pharmacol 1994; 47: 1079-87.
21. Hanigan MH, Gallggher BC, Taylor PT, Large MK. Inhibition of γ-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity. Cancer Res 1994; 54: 5925-9.
22. 4 by membrane vesicles prepared from cisplatin-resistant human epidermoid carcinoma tumor cells. J Natl Cancer Inst 1994; 86: 1781-4.
23. 4 transporter in cisplatin-resistant human KB cells. Biochem Biophys Res Commun 1996; 226: 158-65.